Prevention of isoproterenol-induced cardiac hypertrophy by eugenol, an antioxidant

  • Rashmi Choudhary
  • K. P. Mishra
  • C. SubramanyamEmail author


Recent reports on the involvement of calcineurin in cardiac hypertrophy and its susceptibility to free radicals, prompted us to examine possible beneficial effects of dietary antioxidants in this regard. In continuation of initialin vitro studies revealing eugenol to be a potent calcineurin inhibitor, we investigated its ability to reverse isoproterenol-induced cardiac hypertrophy in rats. Intraperitoneal administration of isoproterenol (1 mg/kg body wt/day for 10 days) induced cardiac hypertrophy with increased heart weight and enhanced apoptosis of myocytes concomitant with accumulation of reactive oxygen species, decreased glutathione contents, increased activities of calcineurin and protein kinase C in ventricular tissue. Administering eugenol for 3 days (1 mg/kg body wt/twice a day), followed by combined administration of isoproterenol and eugenol resulted in significant reversal of cardiac hypertrophy and restoration of above changes. These results suggest that eugenol, a natural antioxidant of dietary origin, may offer potential benefits in the management of cardiac hypertrophy.

Key Words

Antioxidants Calcineurin activity Cardiac hypertrophy Eugenol ROS Isoproterenol 


  1. 1.
    Braun, M., Simonis, G., Birkner, K., Pauke, B. and Strasser, R.H. (2003) Regulation of protein kinase C isozyme and calcineurin expression in isoproterenol induced cardiac hypertrophy. J. Cardiovasc. Pharmacol. 41, 946–954.PubMedCrossRefGoogle Scholar
  2. 2.
    Cao, Z., Tsang, M., Zhao, H. and Li, Y (2003) Induction of endogenous antioxidants and phase 2 enzymes by a-lipoic acid in rat cardiac H9C2 cells: protection against oxidative injury. Biochem. Biophys. Res. Commun. 310, 979–985.PubMedCrossRefGoogle Scholar
  3. 3.
    Chattopadhyay, A., Biswas, S., Bandyopadhyay, D., Sarkar, C. and Datta, A. G. (2003) Effect of isoproterenol on lipid peroxidation and antioxidant enzymes of myocardial tissue of mice and protection by quinidine. Mol. Cell. Biochem. 245, 43–49.PubMedCrossRefGoogle Scholar
  4. 4.
    FAO (1982) Evaluation of certain food additives and contaminants. Technical Report Series No. 20. FAO/WHO Expert Committee on food additives.Google Scholar
  5. 5.
    Hissin, P.J. and Hilf, R (1976) A fluorimetric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 74, 214–226.PubMedCrossRefGoogle Scholar
  6. 6.
    Huang, Y.C., Wu, B.N., Lin, Y.T., Chen, S.J., Chiu, C.C., Cheng, C.J. and Chen, I.J. (1999) Eugenodilol: a third-generation beta-adrenoceptor blocker, derived from eugenol, with alpha-adrenoceptor blocking and beta2-adrenoceptor agonist-associated vasorelaxant activities. J. Cardiovasc. Pharmacol. 34, 10–20.PubMedCrossRefGoogle Scholar
  7. 7.
    Jayashree, T. and Subramanyam, C. (1999) Antiaflatoxigenic activity of eugenol is due to inhibition of lipid peroxidation. Lett. Appl Microbiol. 28, 179–183.PubMedCrossRefGoogle Scholar
  8. 8.
    Kang, Y.J., Zhou, Z.X., Wu, H., Wang, G.W., Saari, J.T. and Klein, J.B. (2000) Metallothionein inhibits myocardial apoptosis in copper-deficient mice: role of atrial natriuretic peptide. Lab. Invest. 80, 745–757.PubMedGoogle Scholar
  9. 9.
    Leinwand, L.A. (2001) Calcineurin inhibition and cardiac hypertrophy: A matter of balance. Proc. Natl. Acad. Sci. USA. 98, 2947–2949.PubMedCrossRefGoogle Scholar
  10. 10.
    Lin, Y.T., Wu, B.N., Horng, C.F., Huang, Y.C., Hong, S.J., Lo, Y.C., Cheng, C.J. and Chen, I.J. (1999) Isoeugenolol: A selective beta 1-drenergic antagonist with tracheal and vascular smooth muscle relaxant properties. Jpn. J. Pharmacol. 80, 127–136.PubMedCrossRefGoogle Scholar
  11. 11.
    Lipkin, G.W., Tucker, B., Giles, M. and Raine, A.E. (1993) Ambulatory blood pressure and left ventricular mass in cyclosporin and not cyclosporin treated renal transplant recipients. J. Hypertens. 11, 439–442.PubMedCrossRefGoogle Scholar
  12. 12.
    Marklund, S. and Marklund, G. (1974) Involvement of the superoxide anion radical in the auto oxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 47, 469–474.PubMedCrossRefGoogle Scholar
  13. 13.
    Martinez, J.I.R., Launay, J.M. and Dreux, C (1979) A sensitive flourimetric microassay for glutathione peroxidase activity. Application to human blood platelets. Anal. Biochem. 98, 154–159.PubMedCrossRefGoogle Scholar
  14. 14.
    Meguro, T., Hong, C., Asai, K., Takagi, G., McKinsey, T.A., Olson, E.N. and Vatner, S.F. (1999) Cyclosporine attenuates pressure overload hypertrophy in mice while enhancing susceptibility to decompensation and heart failure. Circ. Res. 84, 735–740.PubMedGoogle Scholar
  15. 15.
    Miyashita, T., Takeishi, Y., Takahashi, H., Kato, S., Kubota, I. and Tomoike, H. (2001) Role of calcineurin in insulin-like growth factor-1-induced hypertrophy of cultured adult rat ventricular myocytes. Jpn. Circ. J. 65, 815–819.PubMedCrossRefGoogle Scholar
  16. 16.
    Molkentin, J., Lu, J., Antos, C., Markham, B., Richardson, J., Robbins, J., Grant, S. and Olson, E.N. (1998) A calcineurin dependent transcriptional pathway for cardiac hypertrophy. Cell. 93, 215–228.PubMedCrossRefGoogle Scholar
  17. 17.
    Molkentin, J.D. (2000) Calcineurin and beyond: Cardiac hypertrophy signaling. Circ. Res. 87, 731–738.PubMedGoogle Scholar
  18. 18.
    Nagata, K., Somura, F., Obata, K., Odashima, M., Izawa, H., Ichihara, S., Nagasaka, T., Iwase, M., Yamada, Y., Nakashima, N. and Yokota, M. (2002) AT1 receptor blockade reduces cardiac calcineurin activity in hypertensive rats. Hypertension. 40, 168–74.PubMedCrossRefGoogle Scholar
  19. 19.
    Padma, S. and Subramanyam, C. (1999) Extracellular calcineurin: Identification and quantitation in serum and amniotic fluid. Clin. Biochem. 32, 491–494.PubMedCrossRefGoogle Scholar
  20. 20.
    Pandey, B.N. and Mishra, K.P. (2003) Modification of thymocytes membrane radio-oxidative damage and apoptosis by eugenol. J. Environ. Pathol. Toxicol. Oncol. in Press;Google Scholar
  21. 21.
    Saccani, S., Saccani, A., Varesio, L., Ghosh, P., Young, H.A. and Sica, A. (1999) Divergent effects of dithiocarbamates on AP-1-containing and AP-1-less NFAT sites. Eur. J. Immunol. 29, 1194–1201.PubMedCrossRefGoogle Scholar
  22. 22.
    Sawyer, D.B., Siwik, D.A., Xiao, L., Pimentel, D.R., Singh, K. and Colucci, W.S. (2002) Role of oxidative stress in myocardial hypertrophy and failure. J. Mol. Cell. Cardiol. 34, 379 {INCLUDEPICTURE “”/*MERGEFORMATINET}388.PubMedCrossRefGoogle Scholar
  23. 23.
    Sharma, J.N., Srivastava, K.C. and Gan, E.K. (1994) Suppressive effects of eugenol and ginger oil on arthritic rats. Pharmacology. 49, 314–318.PubMedCrossRefGoogle Scholar
  24. 24.
    Shizukuda, Y., Buttrick, P.M., Geenen, D.L., Borczuk, A.C., Kitsis, R.N. and Sonnenblick, E.H. (1998) beta-adrenergic stimulation causes cardiocyte apoptosis: influence of tachycardia and hypertrophy. Am. J. Physiol. 275, H961-H968.PubMedGoogle Scholar
  25. 25.
    Snedecor, G.W. and Cochran, W.G. (1986) Shortcut and non-parametric methods. In: Statistical methods, Eds. Snedecor, G.W. and Cochran, W.G., Oxford and IBH, New Delhi, 120–132.Google Scholar
  26. 26.
    Sugden, P.H. (2001) Signalling pathways in cardiac myocyte hypertrophy. Ann. Med. 33, 611–622.PubMedGoogle Scholar
  27. 27.
    Terzian, A.R. and Rubin, R.P. (1993) Translocation of the á-isozyme of protein kinase C during stimulation of rat parotid acinar cells by phorbol ester and carbachol. Archives. Oral. Biol. 38, 1051–1056.CrossRefGoogle Scholar
  28. 28.
    Wang, X., Culotta, V.C. and Klee, C.B. (1996) Superoxide dismutase protects calcineurin from inactivation. Nature. 383, 434–437.PubMedCrossRefGoogle Scholar
  29. 29.
    Zou, Y., Yao, A., Zhu, W., Kudoh, S., Hiroi, Y., Shimoyama, M., Uozumi, H., Kohmoto, O., Takahashi, T., Shibasaki, F., Nagai, R., Yazaki, Y. and Komuro, I (2001) Isoproterenol activates extracellular signal-regulated protein kinases in cardiomyocytes through calcineurin. Circulation. 104, 102–108.PubMedCrossRefGoogle Scholar

Copyright information

© Association of Clinical BIochemists of India 2006

Authors and Affiliations

  • Rashmi Choudhary
    • 1
  • K. P. Mishra
    • 2
  • C. Subramanyam
    • 1
    Email author
  1. 1.Department of BiochemistryOsmania UniversityHyderabad
  2. 2.Radiation Biology and Health Sciences DivisionBhabha Atomic Research CentreMumbaiIndia

Personalised recommendations